SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
FRA:SHL - DE000SHL1006 - Common Stock
47.24 EUR
+0.1 (+0.21%)
We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 57 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SHL while its profitability can be described as average. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
SHL had a positive operating cash flow in the past year.
Each year in the past 5 years SHL has been profitable.
SHL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.87%, SHL is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
SHL's Return On Equity of 12.29% is fine compared to the rest of the industry. SHL outperforms 77.19% of its industry peers.
With a decent Return On Invested Capital value of 7.89%, SHL is doing good in the industry, outperforming 73.68% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 8.81%.
The last Return On Invested Capital (7.89%) for SHL is above the 3 year average (5.87%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
SHL has a better Profit Margin (9.29%) than 70.18% of its industry peers.
SHL's Profit Margin has declined in the last couple of years.
SHL has a Operating Margin of 13.76%. This is in the better half of the industry: SHL outperforms 68.42% of its industry peers.
SHL's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 38.76%, SHL is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
The number of shares outstanding for SHL has been increased compared to 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
SHL has a better debt/assets ratio than last year.
2.2 Solvency
SHL has an Altman-Z score of 2.07. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SHL (2.07) is comparable to the rest of the industry.
The Debt to FCF ratio of SHL is 5.10, which is a neutral value as it means it would take SHL, 5.10 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.10, SHL perfoms like the industry average, outperforming 59.65% of the companies in the same industry.
SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of SHL (0.66) is worse than 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.07 |
ROIC/WACC1.32
WACC5.98%
2.3 Liquidity
SHL has a Current Ratio of 1.12. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.12, SHL is doing worse than 71.93% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that SHL may have some problems paying its short term obligations.
SHL has a Quick ratio of 0.77. This is in the lower half of the industry: SHL underperforms 70.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
SHL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.21%, which is quite good.
SHL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.27% yearly.
The Revenue has been growing slightly by 5.85% in the past year.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.77% on average per year.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.15% on average per year.
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.77%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.15%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.85 indicates a rather expensive valuation of SHL.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 82.46% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SHL to the average of the S&P500 Index (27.06), we can say SHL is valued slightly cheaper.
SHL is valuated rather expensively with a Price/Forward Earnings ratio of 18.04.
73.68% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
SHL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.85 | ||
| Fwd PE | 18.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 87.72% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.32 | ||
| EV/EBITDA | 14.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.07
PEG (5Y)2.73
EPS Next 2Y8.35%
EPS Next 3Y9.57%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.01%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.32, SHL pays a better dividend. On top of this SHL pays more dividend than 80.70% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
5.2 History
On average, the dividend of SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
SHL pays out 49.08% of its income as dividend. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.08%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
FRA:SHL (9/5/2025, 7:00:00 PM)
47.24
+0.1 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.29B
Analysts83.7
Price Target61.88 (30.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0.1%
PT rev (3m)-2.25%
EPS NQ rev (1m)-4.68%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.35%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.85 | ||
| Fwd PE | 18.04 | ||
| P/S | 2.28 | ||
| P/FCF | 17.32 | ||
| P/OCF | 13.86 | ||
| P/B | 3.01 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.55 |
EPS(TTM)2.38
EY5.04%
EPS(NY)2.62
Fwd EY5.54%
FCF(TTM)2.73
FCFY5.77%
OCF(TTM)3.41
OCFY7.22%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.07
PEG (5Y)2.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.07 |
F-Score8
WACC5.98%
ROIC/WACC1.32
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.77%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.15%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.6%
EBIT Next 3Y21.79%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%